These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1687963)

  • 1. A two-part model of stimulant action on attention-deficit hyperactivity disorder in children.
    McCracken JT
    J Neuropsychiatry Clin Neurosci; 1991; 3(2):201-9. PubMed ID: 1687963
    [No Abstract]   [Full Text] [Related]  

  • 2. The mechanism of action of drugs used to treat attention-deficit hyperactivity disorder: focus on catecholamine receptor pharmacology.
    Shenker A
    Adv Pediatr; 1992; 39():337-82. PubMed ID: 1359740
    [No Abstract]   [Full Text] [Related]  

  • 3. Stimulant drug action in attention deficit hyperactivity disorder (ADHD): inference of neurophysiological mechanisms via quantitative modelling.
    Rowe DL; Robinson PA; Gordon E
    Clin Neurophysiol; 2005 Feb; 116(2):324-35. PubMed ID: 15661111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does stimulant medication decrease the lower extremity response times of children with and without attention-deficit/hyperactivity disorder?
    Brasić JR
    Percept Mot Skills; 2007 Feb; 104(1):67-8. PubMed ID: 17450965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The action of stimulant medication in attention deficit disorder with hyperactivity: dopaminergic, noradrenergic, or both?
    Levy F; Hobbes G
    J Am Acad Child Adolesc Psychiatry; 1988 Nov; 27(6):802-5. PubMed ID: 2848797
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of action of stimulants in attention-deficit/hyperactivity disorder.
    Stahl SM
    J Clin Psychiatry; 2010 Jan; 71(1):12-3. PubMed ID: 20129003
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine receptors and the pharmacogenetics of side-effects of stimulant treatment for attention-deficit/hyperactivity disorder.
    Levy F; Wimalaweera S; Moul C; Brennan J; Dadds MR
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):423-5. PubMed ID: 23952191
    [No Abstract]   [Full Text] [Related]  

  • 8. Stimulants and growth in children with attention-deficit/hyperactivity disorder.
    Negrao BL; Viljoen M
    Med Hypotheses; 2011 Jul; 77(1):21-8. PubMed ID: 21444155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.
    Solanto MV
    Psychol Bull; 1984 May; 95(3):387-409. PubMed ID: 6152684
    [No Abstract]   [Full Text] [Related]  

  • 10. Toward a pathophysiology of attention-deficit/hyperactivity disorder.
    Castellanos FX
    Clin Pediatr (Phila); 1997 Jul; 36(7):381-93. PubMed ID: 9241475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-hyperactivity medication: methylphenidate and amphetamine.
    Seeman P; Madras BK
    Mol Psychiatry; 1998 Sep; 3(5):386-96. PubMed ID: 9774771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder.
    Staller JA; Faraone SV
    Expert Rev Neurother; 2007 Apr; 7(4):351-62. PubMed ID: 17425490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothesis for prediction of stimulant drug effectiveness utilizing sensory integrative diagnostic methods.
    Kimball JG
    J Am Osteopath Assoc; 1988 Jun; 88(6):757-62. PubMed ID: 2899572
    [No Abstract]   [Full Text] [Related]  

  • 14. Photic responses in "minimal brain dysfunction".
    Milstein V; Small JG
    Dis Nerv Syst; 1974 Aug; 35(8):355-7. PubMed ID: 17894071
    [No Abstract]   [Full Text] [Related]  

  • 15. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects.
    Hart H; Radua J; Nakao T; Mataix-Cols D; Rubia K
    JAMA Psychiatry; 2013 Feb; 70(2):185-98. PubMed ID: 23247506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lisdexamfetamine dimesylate.
    Elia J; Easley C; Kirkpatrick P
    Nat Rev Drug Discov; 2007 May; 6(5):343-4. PubMed ID: 17539056
    [No Abstract]   [Full Text] [Related]  

  • 17. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zeroing in on attention deficit disorder.
    Health News; 1999 Feb; 5(2):7. PubMed ID: 9972114
    [No Abstract]   [Full Text] [Related]  

  • 19. Subtypes of aggression in children with attention deficit hyperactivity disorder: medication effects and comparison with typical children.
    King S; Waschbusch DA; Pelham WE; Frankland BW; Corkum PV; Jacques S
    J Clin Child Adolesc Psychol; 2009 Sep; 38(5):619-29. PubMed ID: 20183647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dopamine theory of attention deficit hyperactivity disorder (ADHD).
    Levy F
    Aust N Z J Psychiatry; 1991 Jun; 25(2):277-83. PubMed ID: 1652243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.